USGrantedDrug combination
Compositions and methods comprising a combination of serotonergic drugs
US-11974984-B2
Bibliographic data
- Patent number
- US-11974984-B2
- Jurisdiction
- US
- Status
- Granted
- Type
- Drug combination
- Priority date
- 9 February 2017
- Filing date
- 11 November 2020
- Grant date
- 7 May 2024
Compounds claimed
Analysis
This is the case that best illustrates what a curated prior-art library can do. CaaMTech applied for broad claims over combinations of serotonergic drugs, psilocybin, LSD and MDMA, paired with cannabinoids, terpenes and SSRIs.
Porta Sophia filed a third-party submission in November 2021. The original eighteen claims were cancelled and narrowed to seven before the patent granted in 2024. It is a concrete example of prior art shaping the boundaries of a patent rather than blocking it outright, which is often the more realistic and more useful outcome.
Third-party submission
- Challenged application
- Compositions and methods comprising a combination of serotonergic drugs
- Application number
- US 17/095,430
- Assignee / inventor
- CaaMTech, Inc. / Andrew R. Chadeayne
Prosecution log
Porta Sophia filed a third-party preissuance submission of prior art against the application.
Granted as US-11974984-B2 with claims narrowed from the original 18 to 7.